Pharmaceutical companies are well regarded in the pandemic. But in the long run, exorbitant profits could undermine the companies’ credibility, argues business ethicist Prof. Markus Scholz. After all, companies also bear political responsibility for the distribution of vaccines.
Listen to the entire interview here (in German).